European CHMP recommends approval of remimazolam (Byfavo) for procedural sedation
Remimazolam is an ultra-short acting benzodiazepine sedative that will be available as a powder for solution for injection (20 mg).
Source:
European Medicines Agency
Remimazolam is an ultra-short acting benzodiazepine sedative that will be available as a powder for solution for injection (20 mg).
European Medicines Agency